The Imaging and Probes Resource will provide a seamless translational approach that will integrate multimodality MR, PET, SPECT, and optical imaging and probe development to understand and effectively treat cancer. The research studies in this JHU ICMIC application require a wide range of imaging methods and imaging probe development that span the imaging of microscopic structures such as collagen 1 fibers, to preclinical imaging of human cancer xenografts and transgenic models, to imaging cancer patients. This resource will provide the requisite infrastructure and act as a central resource for JHU ICMIC investigators to obtain expertise and assistance for multi-modality imaging, image visualization and analyses, and imaging probe development. This resource will also perform research and development in imaging and probe development in the JHU ICMIC. The resource will play a valuable role in identifying and developing novel imaging technologies and probes as individual research projects evolve within the program.
The aims of this resource are to: (i) Guide and assist investigators in the use of imaging technologies, and to identify the most appropriate imaging technology for the research studies, (ii) Develop and provide state-of- the-art image analyses and visualization necessary for multi-modality imaging data, (iii) Identify, develop, and provide novel contrast agents for MR, radionuclide, and optical imaging applications, (iv) Develop agents against critical targets identified during the course of the research programs in the center, (v) Identify the most promising preclinical Imaging techniques and agents for future clinical use. Members of this resource are versatile in imaging and probe development and can function interchangeably in this resource resulting in a commonality of effort.
The Imaging and Probes Resource is a cornerstone of our JHU ICMIC as it is the centralized resource that assists investigators in imaging and probe development. It will also lead advances in imaging and probes, and interact with the Molecular Oncology Resource in advancing our purpose of applying molecular imaging to advance cancer discovery and treatment.
|Penet, Marie-France; Shah, Tariq; Bharti, Santosh et al. (2015) Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res 21:386-95|
|Ahn, Eun Hyun; Kim, Younghoon; Kshitiz et al. (2014) Spatial control of adult stem cell fate using nanotopographic cues. Biomaterials 35:2401-10|
|El Khouli, Riham H; Macura, Katarzyna J; Kamel, Ihab R et al. (2014) The effects of applying breast compression in dynamic contrast material-enhanced MR imaging. Radiology 272:79-90|
|Nimmagadda, Sridhar; Pullambhatla, Mrudula; Lisok, Ala et al. (2014) Imaging Axl expression in pancreatic and prostate cancer xenografts. Biochem Biophys Res Commun 443:635-40|
|Yadav, Nirbhay N; Xu, Jiadi; Bar-Shir, Amnon et al. (2014) Natural D-glucose as a biodegradable MRI relaxation agent. Magn Reson Med 72:823-8|
|Gadiya, Mayur; Mori, Noriko; Cao, Maria D et al. (2014) Phospholipase D1 and choline kinase-? are interactive targets in breast cancer. Cancer Biol Ther 15:593-601|
|Shamir, Eliah R; Pappalardo, Elisa; Jorgens, Danielle M et al. (2014) Twist1-induced dissemination preserves epithelial identity and requires E-cadherin. J Cell Biol 204:839-56|
|Huang, Peng; Ou, Ai-hua; Piantadosi, Steven et al. (2014) Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials 39:294-302|
|Subhawong, Ty K; Jacobs, Michael A; Fayad, Laura M (2014) Insights into quantitative diffusion-weighted MRI for musculoskeletal tumor imaging. AJR Am J Roentgenol 203:560-72|
|Zhu, Wenlian; Kato, Yoshinori; Artemov, Dmitri (2014) Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy. MAGMA 27:161-70|
Showing the most recent 10 out of 142 publications